| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Michael E Greenberg | |
| Daniel H Ebert | |||
| P2860 | cites work | Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. | Q48354837 |
| Stimulation of neuronal acetylcholine receptors induces rapid gene transcription | Q69602070 | ||
| Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin | Q22010466 | ||
| Advances in autism genetics: on the threshold of a new neurobiology | Q22251023 | ||
| Neuroligins and neurexins link synaptic function to cognitive disease | Q22251092 | ||
| Correction of fragile X syndrome in mice. | Q22251255 | ||
| The Autistic Neuron: Troubled Translation? | Q22252314 | ||
| Postnatal development of the visual cortex and the influence of environment | Q22337285 | ||
| LTP and LTD | Q22337342 | ||
| SHANK1 Deletions in Males with Autism Spectrum Disorder | Q24313471 | ||
| Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments | Q24328996 | ||
| Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function | Q24338263 | ||
| Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome | Q24530286 | ||
| Altered synaptic plasticity in a mouse model of fragile X mental retardation | Q24530695 | ||
| Functional impact of global rare copy number variation in autism spectrum disorders | Q24596191 | ||
| Shank3 mutant mice display autistic-like behaviours and striatal dysfunction | Q24597501 | ||
| SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1 | Q24618070 | ||
| A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice | Q24629938 | ||
| FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism | Q24631425 | ||
| Rate of de novo mutations and the importance of father's age to disease risk | Q24632353 | ||
| Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis | Q24648897 | ||
| Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system | Q24650727 | ||
| Identifying autism loci and genes by tracing recent shared ancestry | Q24655308 | ||
| Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2 | Q26269865 | ||
| Synaptic cell adhesion | Q26269885 | ||
| An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus | Q26269889 | ||
| The pathophysiology of fragile X (and what it teaches us about synapses) | Q27010675 | ||
| CNVs: harbingers of a rare variant revolution in psychiatric genetics | Q27022289 | ||
| Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism | Q28117072 | ||
| The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses | Q28208647 | ||
| Translational control by MAPK signaling in long-term synaptic plasticity and memory | Q28249953 | ||
| Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) | Q28252295 | ||
| Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression | Q28257629 | ||
| Patterns and rates of exonic de novo mutations in autism spectrum disorders | Q28264242 | ||
| Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 | Q28268807 | ||
| Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 | ||
| Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome | Q28505346 | ||
| MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function | Q28507026 | ||
| MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number | Q28507266 | ||
| Activity-dependent regulation of inhibitory synapse development by Npas4 | Q28510423 | ||
| Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD | Q28585633 | ||
| High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism | Q28730279 | ||
| Degradation of postsynaptic scaffold GKAP and regulation of dendritic spine morphology by the TRIM3 ubiquitin ligase in rat hippocampal neurons | Q28748325 | ||
| Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 | Q28941210 | ||
| Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism | Q29013643 | ||
| De novo mutations revealed by whole-exome sequencing are strongly associated with autism | Q29547269 | ||
| The molecular biology of memory storage: a dialogue between genes and synapses | Q29547845 | ||
| Widespread transcription at neuronal activity-regulated enhancers | Q29614330 | ||
| Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations | Q29614573 | ||
| The mGluR theory of fragile X mental retardation | Q29615060 | ||
| Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation | Q29616327 | ||
| Reversal of neurological defects in a mouse model of Rett syndrome | Q29616452 | ||
| Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system | Q29617400 | ||
| Regulation of dendritic spine morphology and synaptic function by Shank and Homer | Q30014842 | ||
| Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome | Q30529349 | ||
| The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. | Q33744301 | ||
| A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity | Q34062918 | ||
| MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants | Q34086410 | ||
| Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway | Q34094970 | ||
| Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism | Q34236650 | ||
| Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways | Q34334761 | ||
| Synaptic protein degradation underlies destabilization of retrieved fear memory | Q34747479 | ||
| Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
| Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice | Q34856164 | ||
| A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition | Q34889693 | ||
| Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling | Q35047447 | ||
| Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia | Q35104642 | ||
| Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. | Q35114553 | ||
| Mutations causing syndromic autism define an axis of synaptic pathophysiology | Q35587150 | ||
| Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. | Q35629499 | ||
| Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities | Q35765423 | ||
| Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. | Q35949697 | ||
| Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. | Q36025486 | ||
| CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease | Q36281961 | ||
| Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. | Q36752504 | ||
| The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels | Q36883128 | ||
| Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate | Q36966248 | ||
| Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection | Q37070840 | ||
| Communication between the synapse and the nucleus in neuronal development, plasticity, and disease | Q37212202 | ||
| From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function | Q37279404 | ||
| Ube3a is required for experience-dependent maturation of the neocortex. | Q37340937 | ||
| The conundrums of understanding genetic risks for autism spectrum disorders | Q37613535 | ||
| Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease | Q37827231 | ||
| TSC1/TSC2 signaling in the CNS. | Q37844199 | ||
| The postsynaptic organization of synapses | Q37951923 | ||
| PTEN signaling in autism spectrum disorders | Q38015944 | ||
| Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function | Q39461991 | ||
| Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. | Q40372504 | ||
| Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory | Q40888422 | ||
| Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. | Q41844282 | ||
| Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome | Q41849184 | ||
| Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function | Q42049245 | ||
| NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). | Q42184021 | ||
| RETRACTED: Imaging Activity-Dependent Regulation of Neurexin-Neuroligin Interactions Using trans-Synaptic Enzymatic Biotinylation | Q42393682 | ||
| A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication | Q43615606 | ||
| Phosphorylation influences the translation state of FMRP-associated polyribosomes | Q44626609 | ||
| FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. | Q46832201 | ||
| Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. | Q48294933 | ||
| P433 | issue | 7432 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| autism spectrum disorder | Q1436063 | ||
| P304 | page(s) | 327-337 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Activity-dependent neuronal signalling and autism spectrum disorder | |
| P478 | volume | 493 |
| Q56459678 | 5-Hydroxymethylcytosine alterations in the human postmortem brains of autism spectrum disorder |
| Q38834709 | A Consensus Network of Gene Regulatory Factors in the Human Frontal Lobe |
| Q38914044 | A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density |
| Q28079929 | A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons. |
| Q38161847 | A blueprint for research on Shankopathies: a view from research on autism spectrum disorder |
| Q30273799 | A coding-independent function of an alternative Ube3a transcript during neuronal development |
| Q89014726 | A comparative study of the genetic components of three subcategories of autism spectrum disorder |
| Q21129104 | A comparison of neuroimaging findings in childhood onset schizophrenia and autism spectrum disorder: a review of the literature |
| Q27320751 | A computational perspective on autism |
| Q34775670 | A quantitative framework to evaluate modeling of cortical development by neural stem cells |
| Q92204157 | ARNT2 Tunes Activity-Dependent Gene Expression through NCoR2-Mediated Repression and NPAS4-Mediated Activation |
| Q47872240 | Aberrant cognitive phenotypes and altered hippocampal BDNF expression related to epigenetic modifications in mice lacking the post-synaptic scaffolding protein SHANK1: Implications for autism spectrum disorder. |
| Q43062745 | Activity-Dependent Changes in Gene Expression in Schizophrenia Human-Induced Pluripotent Stem Cell Neurons |
| Q57793727 | Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior |
| Q64881923 | Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome. |
| Q41887773 | Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. |
| Q28273413 | Adult restoration of Shank3 expression rescues selective autistic-like phenotypes |
| Q28069757 | Advancing the understanding of autism disease mechanisms through genetics |
| Q48043088 | Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism |
| Q58122132 | Alpha2-Containing Glycine Receptors Promote Neonatal Spontaneous Activity of Striatal Medium Spiny Neurons and Support Maturation of Glutamatergic Inputs |
| Q30596522 | Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. |
| Q50301911 | Altered mTORC1 signaling in multipotent stem cells from nearly 25% of patients with nonsyndromic autism spectrum disorders |
| Q37350682 | Alternative polyadenylation and differential expression of Shank mRNAs in the synaptic neuropil |
| Q38678076 | Anatomy and Cell Biology of Autism Spectrum Disorder: Lessons from Human Genetics |
| Q30845989 | Anchoring and synaptic stability of PSD-95 is driven by ephrin-B3. |
| Q41931342 | Arc - An endogenous neuronal retrovirus? |
| Q38139257 | Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives |
| Q41933122 | Autism and Epilepsy: Exploring the Relationship Using Experimental Models |
| Q37394661 | Autism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence |
| Q100525907 | Autism spectrum disorder-like behavior caused by reduced excitatory synaptic transmission in pyramidal neurons of mouse prefrontal cortex |
| Q58617587 | Autism spectrum disorder: insights into convergent mechanisms from transcriptomics |
| Q35595728 | Autism spectrum disorders: emerging mechanisms and mechanism-based treatment. |
| Q27320813 | Autism-Associated Chromatin Regulator Brg1/SmarcA4 Is Required for Synapse Development and Myocyte Enhancer Factor 2-Mediated Synapse Remodeling |
| Q90161180 | Autism-associated PTEN missense mutation leads to enhanced nuclear localization and neurite outgrowth in an induced pluripotent stem cell line |
| Q47698460 | Autism-like behavior caused by deletion of vaccinia-related kinase 3 is improved by TrkB stimulation |
| Q51744147 | B-1a lymphocytes promote oligodendrogenesis during brain development. |
| Q38495771 | Brain adaptation and alternative developmental trajectories. |
| Q30358026 | CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders |
| Q40439261 | Cacna1c in the Prefrontal Cortex Regulates Depression-Related Behaviors via REDD1. |
| Q39179475 | Calmodulin kinases: essential regulators in health and disease |
| Q34006563 | Changes in input strength and number are driven by distinct mechanisms at the retinogeniculate synapse. |
| Q92616383 | Changes in the Fluorescence Tracking of NaV1.6 Protein Expression in a BTBR T+Itpr3tf/J Autistic Mouse Model |
| Q37355103 | Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP |
| Q36695840 | Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism |
| Q28066081 | Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder |
| Q39268882 | Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders |
| Q89944606 | Comprehensive Genome-Wide Approaches to Activity-Dependent Translational Control in Neurons |
| Q27027414 | Converging Pathways in Autism Spectrum Disorders: Interplay between Synaptic Dysfunction and Immune Responses |
| Q38174214 | Copy-number variation in the pathogenesis of autism spectrum disorder |
| Q41453777 | Could folic acid influence growth cone motility during the development of neural connectivity? |
| Q37444926 | Current Perspectives in Autism Spectrum Disorder: From Genes to Therapy |
| Q61444494 | DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients |
| Q28833595 | DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? |
| Q28082410 | Deceivingly dynamic: Learning-dependent changes in stathmin and microtubules |
| Q30829767 | Deep phenotyping unveils hidden traits and genetic relations in subtle mutants |
| Q55691565 | Defective Synapse Maturation and Enhanced Synaptic Plasticity in Shank2 Δex7–/– Mice. |
| Q40934865 | Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms. |
| Q93217448 | Defects in syntabulin-mediated synaptic cargo transport associate with autism-like synaptic dysfunction and social behavioral traits |
| Q37719035 | Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins |
| Q38122448 | Developing new pharmacotherapies for autism. |
| Q26768284 | Developmental Dynamics of Rett Syndrome |
| Q33670572 | Developmental and adult GAP-43 deficiency in mice dynamically alters hippocampal neurogenesis and mossy fiber volume |
| Q47564009 | Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism |
| Q47895125 | Developmental timing and critical windows for the treatment of psychiatric disorders. |
| Q58750661 | Diet-Induced Obesity Elicits Macrophage Infiltration and Reduction in Spine Density in the Hypothalami of Male but Not Female Mice |
| Q58580308 | Dietary Zinc Supplementation Prevents Autism Related Behaviors and Striatal Synaptic Dysfunction in Exon 13-16 Mutant Mice |
| Q89534245 | Differential Expression of Hippocampal Circular RNAs in the BTBR Mouse Model for Autism Spectrum Disorder |
| Q46368324 | Discovery of nitrate-CPK-NLP signalling in central nutrient-growth networks. |
| Q37714594 | Distinct Defects in Spine Formation or Pruning in Two Gene Duplication Mouse Models of Autism. |
| Q35635057 | Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis |
| Q39010547 | Does treatment have an impact on incidence and risk factors for autism spectrum disorders in children with infantile spasms? |
| Q41684291 | Dysregulation of Alternative Poly-adenylation as a Potential Player in Autism Spectrum Disorder |
| Q64931149 | Early Seizures Prematurely Unsilence Auditory Synapses to Disrupt Thalamocortical Critical Period Plasticity. |
| Q21129477 | Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons |
| Q92688392 | Emerging connections between cerebellar development, behaviour and complex brain disorders |
| Q49646234 | Emerging themes in neuronal activity-dependent gene expression |
| Q34636247 | Epigenetic control of learning and memory in Drosophila by Tip60 HAT action |
| Q48021140 | Excessive D1 Dopamine Receptor Activation in the Dorsal Striatum Promotes Autistic-Like Behaviors |
| Q92022958 | Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders |
| Q26796321 | Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders |
| Q30358607 | Eye Tracking Reveals Abnormal Visual Preference for Geometric Images as an Early Biomarker of an Autism Spectrum Disorder Subtype Associated With Increased Symptom Severity |
| Q33578330 | FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity |
| Q37475190 | FMRP and Ataxin-2 function together in long-term olfactory habituation and neuronal translational control. |
| Q36925690 | Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue |
| Q55499041 | Forniceal deep brain stimulation induces gene expression and splicing changes that promote neurogenesis and plasticity. |
| Q37372489 | Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c |
| Q39301735 | From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms |
| Q38569746 | From the genetic architecture to synaptic plasticity in autism spectrum disorder |
| Q91362120 | Functional characterization of human pluripotent stem cell-derived cortical networks differentiated on laminin-521 substrate: comparison to rat cortical cultures |
| Q41967311 | Functional differentiation of stem cell-derived neurons from different murine backgrounds |
| Q59794444 | Gene expression profiling of the olfactory tissues of sex-separated and sex-combined female and male mice |
| Q47552479 | Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease. |
| Q36815646 | Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database |
| Q37739172 | Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism |
| Q38779251 | Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. |
| Q38246625 | Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development |
| Q39485995 | Genetic modifications associated with ketogenic diet treatment in the BTBRT+Tf/J mouse model of autism spectrum disorder |
| Q64240282 | Genetics and epigenetics of autism spectrum disorder-current evidence in the field |
| Q34979894 | Genome-wide identification and characterization of functional neuronal activity-dependent enhancers |
| Q37593513 | Genotype- and sex-dependent effects of altered Cntnap2 expression on the function of visual cortical areas |
| Q38475750 | Heterogeneity of Calcium Channel/cAMP-Dependent Transcriptional Activation |
| Q64115751 | Histone deacetylase inhibitors restore normal hippocampal synaptic plasticity and seizure threshold in a mouse model of Tuberous Sclerosis Complex |
| Q47577142 | Homeostatic Plasticity Shapes Cell-Type-Specific Wiring in the Retina |
| Q47128439 | Homeostatic plasticity shapes the visual system's first synapse |
| Q36933776 | Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome |
| Q28115497 | Human variants in the neuronal basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) transcription factor complex NPAS4/ARNT2 disrupt function |
| Q30409764 | Identification of Mob2, a novel regulator of larval neuromuscular junction morphology, in natural populations of Drosophila melanogaster |
| Q43104046 | Identification of Srp9 as a febrile seizure susceptibility gene |
| Q28655709 | Identification of rare DNA sequence variants in high-risk autism families and their prevalence in a large case/control population |
| Q38550206 | Immune mediators in the brain and peripheral tissues in autism spectrum disorder |
| Q37564195 | Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models |
| Q39749512 | Impaired downregulation of visual cortex during auditory processing is associated with autism symptomatology in children and adolescents with autism spectrum disorder. |
| Q39055780 | In the loop: how chromatin topology links genome structure to function in mechanisms underlying learning and memory |
| Q41437394 | In vivo and in vitro sex differences in the dendritic morphology of developing murine hippocampal and cortical neurons |
| Q37086599 | Inability to activate Rac1-dependent forgetting contributes to behavioral inflexibility in mutants of multiple autism-risk genes |
| Q38829647 | Increased Dosage of High-Affinity Kainate Receptor Gene grik4 Alters Synaptic Transmission and Reproduces Autism Spectrum Disorders Features. |
| Q37058606 | Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. |
| Q41897180 | Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum |
| Q41410549 | Increased signaling by the autism-related Engrailed-2 protein enhances dendritic branching and spine density, alters synaptic structural matching, and exaggerates protein synthesis |
| Q26771402 | Induced pluripotent stem cells for modeling neurological disorders |
| Q27015696 | Inhibition-Based Biomarkers for Autism Spectrum Disorder. |
| Q92709172 | Inhibitory interneurons mediate autism-associated behaviors via 4E-BP2 |
| Q46506229 | Instant Integrated Ultradeep Quantitative-structural Membrane Proteomics Discovered Post-translational Modification Signatures for Human Cys-loop Receptor Subunit Bias. |
| Q47582921 | Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice. |
| Q47165168 | Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children |
| Q55044666 | Integrated genome-wide Alu methylation and transcriptome profiling analyses reveal novel epigenetic regulatory networks associated with autism spectrum disorder. |
| Q41976669 | Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism |
| Q90462310 | Integrative functional genomic analysis of human brain development and neuropsychiatric risks |
| Q34289505 | Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms |
| Q30357060 | Interactions of innate and adaptive immunity in brain development and function. |
| Q64887649 | Investigation of epigenetic regulatory networks associated with autism spectrum disorder (ASD) by integrated global LINE-1 methylation and gene expression profiling analyses. |
| Q47226225 | Is High Folic Acid Intake a Risk Factor for Autism?-A Review |
| Q28771493 | JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse |
| Q61805522 | Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism |
| Q30416844 | Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities |
| Q28829869 | Large-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture System |
| Q37535064 | Late onset deficits in synaptic plasticity in the valproic acid rat model of autism |
| Q38992291 | Lessons learned from studying syndromic autism spectrum disorders |
| Q47954367 | Lineage divergence of activity-driven transcription and evolution of cognitive ability |
| Q37681389 | Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders |
| Q56860940 | Loss of function of MECP2 in Rett syndrome |
| Q38167461 | MET receptor tyrosine kinase as an autism genetic risk factor |
| Q28290639 | Major channels involved in neuropsychiatric disorders and therapeutic perspectives |
| Q92104948 | MeCP2 Deficiency Disrupts Kainate-Induced Presynaptic Plasticity in the Mossy Fiber Projections in the Hippocampus |
| Q52431217 | Meeting Report: Can We Make Animal Models of Human Mental Illness? |
| Q47763262 | Melatonin reverses the decreases in hippocampal protein serine/threonine kinases observed in an animal model of autism |
| Q39185826 | MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia |
| Q47378227 | Microarray analysis of gene expression in the cyclooxygenase knockout mice - a connection to autism spectrum disorder. |
| Q35543490 | Mining the 3'UTR of autism-implicated genes for SNPs perturbing microRNA regulation |
| Q39008875 | Modeling of Autism Using Organoid Technology |
| Q37199033 | Modeling psychiatric disorders: from genomic findings to cellular phenotypes |
| Q26770461 | Molecular Mechanisms Regulating the Dendritic Development of Newborn Olfactory Bulb Interneurons in a Sensory Experience-Dependent Manner |
| Q57243057 | Multimodal sensory processing in |
| Q48170239 | Myelination and mTOR. |
| Q48231673 | NOMA-GAP/ARHGAP33 regulates synapse development and autistic-like behavior in the mouse. |
| Q41916252 | NPAS4 Facilitates the Autophagic Clearance of Endogenous Tau in Rat Cortical Neurons |
| Q36028893 | NPR-9, a Galanin-Like G-Protein Coupled Receptor, and GLR-1 Regulate Interneuronal Circuitry Underlying Multisensory Integration of Environmental Cues in Caenorhabditis elegans |
| Q35633903 | NTRK2 expression levels are reduced in laser captured pyramidal neurons from the anterior cingulate cortex in males with autism spectrum disorder |
| Q37445111 | Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome. |
| Q53400813 | Neonatal maternal deprivation impairs localized de novo activity-induced protein translation at the synapse in the rat hippocampus. |
| Q89064790 | Network organization is globally atypical in autism: A graph theory study of intrinsic functional connectivity |
| Q34601648 | Neural connectivity abnormalities in autism: insights from the Tuberous Sclerosis model. |
| Q47953284 | Neurexin-1 regulates sleep and synaptic plasticity in Drosophila melanogaster. |
| Q38178068 | Neurobiology of autism gene products: towards pathogenesis and drug targets. |
| Q42108909 | Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome |
| Q38342576 | Neuron membrane trafficking and protein kinases involved in autism and ADHD. |
| Q89531500 | Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction |
| Q97884787 | Neuronal Signaling: an introduction |
| Q89477351 | Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors |
| Q38137883 | New innovations: therapeutic opportunities for intellectual disabilities |
| Q28111941 | Nicotinic ACh receptors as therapeutic targets in CNS disorders |
| Q64059020 | Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder |
| Q47308316 | Npas4 deficiency and prenatal stress interact to affect social recognition in mice. |
| Q34363829 | Nuclear calcium signalling in the regulation of brain function |
| Q38442124 | Oxytocin: parallel processing in the social brain? |
| Q60443286 | PCB 95 promotes dendritic growth in primary rat hippocampal neurons via mTOR-dependent mechanisms |
| Q36040491 | PTP1B inhibition suggests a therapeutic strategy for Rett syndrome |
| Q27326861 | PX-RICS-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABAA receptor trafficking |
| Q38448834 | Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling |
| Q93065445 | Patient-Derived Stem Cells, Another in vitro Model, or the Missing Link Toward Novel Therapies for Autism Spectrum Disorders? |
| Q89206465 | Pharmacological Inhibition of ERK Signaling Rescues Pathophysiology and Behavioral Phenotype Associated with 16p11.2 Chromosomal Deletion in Mice |
| Q50655613 | Phencyclidine rapidly decreases neuronal mRNA of brain-derived neurotrophic factor. |
| Q91594920 | Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation |
| Q92403478 | Possible Implication of the CA2 Hippocampal Circuit in Social Cognition Deficits Observed in the Neuroligin 3 Knock-Out Mouse, a Non-Syndromic Animal Model of Autism |
| Q64096561 | Postnatal development and maturation of layer 1 in the lateral prefrontal cortex and its disruption in autism |
| Q42462967 | Postnatal development of dendritic structure of layer III pyramidal neurons in the medial prefrontal cortex of marmoset. |
| Q47270899 | Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders |
| Q41847377 | Profiling the MAPK/ERK dependent and independent activity regulated transcriptional programs in the murine hippocampus in vivo |
| Q38112617 | Progress toward treatments for synaptic defects in autism |
| Q28581600 | Promoter decommissioning by the NuRD chromatin remodeling complex triggers synaptic connectivity in the mammalian brain |
| Q50437928 | Quantitative Phosphoproteomic Analysis of Brain Tissues |
| Q35810058 | Quantitative isoform-profiling of highly diversified recognition molecules. |
| Q26750436 | RELN Mutations in Autism Spectrum Disorder |
| Q38447329 | Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder |
| Q64103670 | Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders |
| Q45967931 | Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. |
| Q38684506 | Recent Advances on Neuromorphic Systems Using Phase-Change Materials |
| Q27000073 | Recent advances in quantitative neuroproteomics |
| Q38263362 | Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders |
| Q36508743 | Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism |
| Q57183231 | Regulation of Neuronal Differentiation, Function, and Plasticity by Alternative Splicing |
| Q98223022 | Rescue of oxytocin response and social behaviour in a mouse model of autism |
| Q54750887 | Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes |
| Q28025533 | Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes |
| Q38366899 | Rett syndrome: a complex disorder with simple roots |
| Q88609435 | Rett syndrome: insights into genetic, molecular and circuit mechanisms |
| Q36715177 | Reversing autism by targeting downstream mTOR signaling |
| Q37173904 | Rit subfamily small GTPases: regulators in neuronal differentiation and survival |
| Q64891599 | SAP97 regulates behavior and expression of schizophrenia risk enriched gene sets in mouse hippocampus. |
| Q21132447 | SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism |
| Q42363268 | Schizophrenia: What's Arc Got to Do with It? |
| Q57287964 | Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors |
| Q41711335 | Sequential chromatin immunoprecipitation to detect SUMOylated MeCP2 in neurons |
| Q59794119 | Sex separation induces differences in the olfactory sensory receptor repertoires of male and female mice |
| Q47683497 | Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression |
| Q37625439 | Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model |
| Q30578795 | Spatially selective photoconductive stimulation of live neurons |
| Q42006907 | Stream-dependent development of higher visual cortical areas |
| Q55261718 | Structural insights and characterization of human Npas4 protein. |
| Q30451745 | Studying autism in rodent models: reconciling endophenotypes with comorbidities |
| Q90195652 | Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS |
| Q43070343 | Synaptic plasticity and cognitive function are disrupted in the absence of Lrp4. |
| Q35080413 | Synaptic synthesis, dephosphorylation, and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5 |
| Q39451309 | Synaptically localized transcriptional regulators in memory formation |
| Q36424672 | Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders |
| Q88644760 | TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration |
| Q27023257 | Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes |
| Q89998822 | Tau Reduction Prevents Key Features of Autism in Mouse Models |
| Q89207617 | The ASD Living Biology: from cell proliferation to clinical phenotype |
| Q47364339 | The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization. |
| Q92294352 | The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression |
| Q47739190 | The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A. |
| Q92862300 | The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases |
| Q26774448 | The Role of the Neuroprotective Factor Npas4 in Cerebral Ischemia |
| Q28572147 | The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines |
| Q49062199 | The bed nucleus of the stria terminalis has developmental and adult forms in mice, with the male bias in the developmental form being dependent on testicular AMH. |
| Q26998540 | The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome |
| Q30586703 | The effects of aging on the BTBR mouse model of autism spectrum disorder |
| Q40859955 | The landscape of copy number variations in Finnish families with autism spectrum disorders |
| Q38259907 | The relevance of human fetal subplate zone for developmental neuropathology of neuronal migration disorders and cortical dysplasia |
| Q34437682 | The social brain network and autism |
| Q37598422 | The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders |
| Q36084776 | Tip60 HAT Action Mediates Environmental Enrichment Induced Cognitive Restoration |
| Q30655543 | Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation |
| Q56860951 | Transcriptional Regulation by MECP2 |
| Q42776718 | Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells |
| Q54961637 | Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. |
| Q38777978 | Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops |
| Q38956328 | Variants of the CNTNAP2 5' promoter as risk factors for autism spectrum disorders: a genetic and functional approach |
| Q97531129 | Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice |
| Q99555072 | Visual Sequences Drive Experience-Dependent Plasticity in Mouse Anterior Cingulate Cortex |
| Q27306360 | Visual circuit development requires patterned activity mediated by retinal acetylcholine receptors |
| Q39010870 | Yin-yang actions of histone methylation regulatory complexes in the brain |
| Q90675178 | hsa-let-7c miRNA Regulates Synaptic and Neuronal Function in Human Neurons |
| Q50074763 | α-Actinin Anchors PSD-95 at Postsynaptic Sites. |
Search more.